Adefovir Dipivoxil, CAS No.: 142340-99-6; Adefovir (PMEA), CAS No.: 106941-25-7; Amisulpride EP5, CAS No.: 71675-85-9; Chlorambucil USP30, CAS No.: 305-03-3; Clopidogrel (For R&D), 113665-84-2; Dacarbazine USP30, CAS No.: 4342-03-4; Darifenacin hydrobromide (R&D), CAS No.: 133099-07-7; Docetaxel CP2005, CAS No.: 114977-28-5; Fludarabine Phosphate USP30, CAS No.: 75607-67-9; Formamidine acetate, CAS No.: 3473-63-0; Gemcitabine HCL USP30, CAS No.: 122111-03-9; Gemcitabine Base, CAS No.: 95058-81-4; Melphalan USP30, CAS No.: 148-82-3; Olopatadine HCL, CAS No.: 140462-76-6; Temozolomide (DMF), CAS No.: 85622-93-1; Voriconazole, CAS No.: 137234-62-9; Hydroxyethyl Starch 130/0.4 & Hydroxyethyl Starch 200/0.5, CAS No.: 9005-27-0; Decitabine (Under Development), CAS No.: 2353-33-5; Ezetimibe (Under Development), CAS No.: 163222-33-1; Febuxostat (Under Development), 144060-53-7; Fosfluconazole (Under Development), CAS No.: 194798-83-9; Luliconazole (Under Development), CAS No.: 187164-19-8; Olmesartan (Under Development), CAS No.: 144690-92-6; Posaconazole (Under Development), CAS No.: 171228-49-2